Results 41 to 50 of about 1,067,070 (316)

Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I‐III rectal cancer

open access: yesCancer Medicine, 2020
Background Preoperative and early postoperative serum carcinoembryonic antigen (CEA) levels are known prognostic factors in rectal cancer. Recently, a large‐scale study on colon cancer revealed that “preoperatively elevated and postoperatively normalized
Yuya Nakamura   +9 more
doaj   +1 more source

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer [PDF]

open access: yes, 2010
Objectives: Bevacizumab is a monoclonal antibody that directly inhibits vascular endothelial growth factor, a key regulator of angiogenesis. Bevacizumab significantly improves progression-free and/or overall survival in metastatic colorectal cancer in ...
Heinemann, Volker, Hoff, Paulo M.
core   +1 more source

Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan

open access: yesBMC Cancer, 2018
Background The incidence of colorectal cancer in adolescent and young adult patients is increasing. However, survival and clinical features of young patients, especially those with stage IV disease, relative to adult patients remain unclear. Methods This
Dai Shida   +8 more
doaj   +1 more source

En bloc resection of a T4B stage cancer of the hepatic flexure of the colon invading the liver, gall bladder, and pancreas/duodenum: A case report

open access: yesClinical Case Reports, 2020
A T4B hepatic flexure of colon cancer that had invaded the liver, gall bladder, and pancreas/duodenum was removed through a D3 expanded right hemicolectomy + pancreaticoduodenectomy +sectional VI and VII hepatic segmentectomy.
Linghou Meng   +8 more
doaj   +1 more source

Recent advances in minimally invasive colorectal cancer surgery [PDF]

open access: yes, 2002
Laparoscopy has improved surgical treatment of various diseases due to its limited surgical trauma and has developed as an interesting therapeutic alternative for the resection of colorectal cancer.
Angele, M. K.   +4 more
core   +1 more source

Habitual intake of flavonoid subclasses and risk of colorectal cancer in two large prospective cohorts [PDF]

open access: yes, 2016
Background: Flavonoids inhibit the growth of colon cancer cells in vitro. In a secondary analysis of a randomized controlled trial, the Polyp Prevention Trial, a higher intake of one sub-class, flavonols, was significantly associated with reduced risk of
Aedín Cassidy   +62 more
core   +1 more source

The importance of circulating tumor products as „liquid biopsies” in colorectal cancer [PDF]

open access: yes, 2018
Liquid biopsies represent an array of plasma analysis tests that are studied to evaluate and identify circulating tumor products, especially circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA).
Calborean, Veronica   +6 more
core   +4 more sources

Preoperative Tattooing Using Indocyanine Green in Laparoscopic Colorectal Surgery [PDF]

open access: yesAnnals of Coloproctology, 2018
Purpose The aim of the present study was to evaluate the usefulness of indocyanine green (ICG) as a preoperative marking dye for laparoscopic colorectal surgery.
Sang Jae Lee   +8 more
doaj   +1 more source

Temporal trends in mode, site and stage of presentation with the introduction of colorectal cancer screening: a decade of experience from the West of Scotland [PDF]

open access: yes, 2015
background:  Population colorectal cancer screening programmes have been introduced to reduce cancer-specific mortality through the detection of early-stage disease.
A Downing   +28 more
core   +2 more sources

FGFR2 amplification in colorectal adenocarcinoma [PDF]

open access: yes, 2017
FGFR2 is recurrently amplified in 5% of gastric cancers and 1%–4% of breast cancers; however, this molecular alteration has never been reported in a primary colorectal cancer specimen.
Carter, Jamal H   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy